Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myeloid × Gemtuzumab × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 15 Leukemia, Erythroblastic, Acute 5 Leukemia 5 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4 Leukemia, Megakaryoblastic, Acute 4 Congenital Abnormalities 3 Myelodysplastic Syndromes 2 Recurrence 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1

Interventions

Imatinib Mesylate 5 ponatinib 4 Cytarabine 4 venetoclax 3 nilotinib 3 Mycophenolic Acid 3 thymoglobulin 2 fludarabine phosphate 2 Lenalidomide 2 Cyclosporine 2 Cyclophosphamide 2 Antilymphocyte Serum 2 quizartinib 1 methanesulfonic acid 1 glasdegib 1 fludarabine 1 etoposide phosphate 1 enasidenib 1 daratumumab 1 bosutinib 1 asciminib 1 Whole-Body Irradiation 1 Transplantation 1 Temozolomide 1 Tacrolimus 1 Stem Cell Transplantation 1 Standard of Care 1 RFT5-SMPT-dgA immunotoxin 1 Peripheral Blood Stem Cell Transplantation 1 N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichlorobenzamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡